论文部分内容阅读
2002年8月,国内多家媒体争相报道了中国华源集团与上海医药集团联合重组的消息,这宗中国医药产业发展史上迄今为止最具影响力的并购案,引起了社会各界的广泛关注。并购重组作为资本运营的一种方式,在现代经济中已经起着越来越重要的作用。在世界经济日趋一体化的背景下,想要让企业立于不败之地,惟有通过扩大企业规模,或重置资产,才有可能从真正达到增强企业实力的目的。但随着并购重组在为企业的发展提供新的机遇的同时,出现的一些问题值得我们深入的思考和探索。据有关统计
In August 2002, many domestic media competed to report the joint reorganization of China Huayuan Group and Shanghai Pharmaceutical Group. The most influential case of M & A in the history of China’s pharmaceutical industry so far has aroused widespread public concern . As a way of capital operation, M & A has played an increasingly important role in the modern economy. In the context of the growing integration of the world economy, enterprises want to be invincible. Only by expanding the scale of enterprises or resetting their assets will it be possible to achieve the objective of enhancing the enterprise’s strength. However, with the mergers and acquisitions provide new opportunities for the development of enterprises at the same time, some problems that arise deserve our in-depth thinking and exploration. According to the statistics